Impact of BRCA in patients undergoing abiraterone stereotactic body radiotherapy: the ARTO trial.
Francolini G, Di Cataldo V, Garlatti P, Bertini N, Aquilano M, Caini S, Ingrosso G, Bruni A, D’Angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Simontacchi G, Jereczek-Fossa BA, Marvaso G, Alongi F, Arcidiacono F, Lancia A, Scorsetti M, Desideri I, Meattini I, Mangoni M, Masieri L, Livi L; ARTO working group members. BJU Int. 2025 Dec 15. doi: 10.1111/bju.70070.
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO).
Borghetti P, D’Angelillo R, Facheris G, Borghesi A, Bruni A, Ceruti P, Ferrari K, Filippi AR, Ramella S, Signorelli D, Pappagallo G, Ricardi U; Collaborators. Lung Cancer. 2025 Dec;210:108807. doi: 10.1016/j.lungcan.2025.108807. Epub 2025 Nov 3. PMID: 41192095
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study.
Bruni A, Franceschini D, Marini B, Vagge S, Ciammella P, Sepulcri M, Grassi R, Gagliardi F, Cappelli A, D’Angelo E, Manetta M, Scricciolo M, Guida C, Fazio I, Borghetti P, Cappabianca S, Nardone V. Clin Lung Cancer. 2025 Sep 30:S1525-7304(25)00237-2. doi: 10.1016/j.cllc.2025.09.012. Online ahead of print.
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial).
Ciammella P, Iori F, Borghetti P, Galaverni M, Alì E, Tiseo M, Pagano M, Sepulcri M, Scotti V, GiajLevra N, Marcenaro M, Simoni N, Nardone V, Botti A, Cozzi S, Bruni A.
Hypofractionated radiotherapy in elderly patients (75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study.
Ingrosso G, Festa E, Caini S, Ponti E, Francolini G, Doccioli C, Lancia A, Fondelli S, Santini R, Valeriani M, Rago L, Bruni A, Augurio A, Trippa F, Russo D, Tamburo M, Parisi S, Borghesi S, Gomellini S, Scoccianti S, Musio D, Stefanacci M, Facondo G, Statuto T, Miranda G, Santo B, Di Marzo A, Bellavita R, Vinciguerra A, Livi L, Aristei C, Detti B. Prostate Cancer Prostatic Dis. 2025 Dec;28(4):938-945. doi: 10.1038/s41391-025-00962-z. Epub 2025 Mar 17.
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, Bruni A, Ingrosso G, D’angelillo RM, Tagliaferri L, Augugliaro M, Triggiani L, Parisi S, Timon G, Arcidiacono F, Marvaso G, Jereczek-Fossa BA, Lancia A, Franzese C, Alongi F, Simontacchi G, Greto D, Bonomo P, Loi M, Frosini G, Burchini L, Desideri I, Meattini I, Valicenti RK, Livi L. Prostate Cancer Prostatic Dis. 2025 Dec;28(4):908-912. doi: 10.1038/s41391-025-00950-3. Epub 2025 Feb 19.
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study.
Nardone V, Bruni A, Franceschini D, Marini B, Vagge S, Ciammella P, Sepulcri M, Cappelli A, D’Angelo E, De Marco G, Angrisani A, Manetta M, Scricciolo M, Guida C, Aiello D, Borghetti P, Cappabianca S. Radiol Med. 2024 Nov;129(11):1700-1709. doi: 10.1007/s11547-024-01885-w. Epub 2024 Aug 31.
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach.
Di Pressa F, Perrone F, Benini A, Lohr F, Tiseo M, Bruni A. Explor Target Antitumor Ther. 2024;5(3):449-464. doi: 10.37349/etat.2024.00228. Epub 2024 May 17.
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).
Ingrosso G, Ponti E, Francolini G, Caini S, Fondelli S, Santini R, Valeriani M, Rago L, Duroni G, Bruni A, Augurio A, Tramacere F, Trippa F, Russo D, Bottero M, Tamburo M, Parisi S, Borghesi S, Lancia A, Gomellini S, Scoccianti S, Stefanacci M, Vullo G, Statuto T, Miranda G, Santo B, Di Marzo A, Bellavita R, Vinciguerra A, Livi L, Aristei C, Bertini N, Orsatti C, Detti B. Radiol Med. 2024 Apr;129(4):643-652. doi: 10.1007/s11547-024-01782-2. Epub 2024 Feb 19.
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis.
Ciammella P, Cozzi S, Borghetti P, Galaverni M, Nardone V, Ruggieri MP, Sepulcri M, Scotti V, Bruni A, Zanelli F, Piro R, Tagliavini E, Botti A, Iori F, Alì E, Bennati C, Tiseo M. Front Oncol. 2024 Jan 31;14:1325249. doi: 10.3389/fonc.2024.1325249. eCollection 2024.
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort.
Borghetti P, Facheris G, Ciammella P, Galaverni M, Granello L, Scotti V, Franceschini D, Romei A, Giaj Levra N, Federico M, La Vecchia M, Merlotti A, Sepulcri M, Piperno G, Marvaso G, Simoni N, Alì E, Pontoriero A, Cappelli A, Dionisi V, Menis J, Martino A, Vagge S, Canova S, Montesi G, Cuccia F, Boldrini L, Franzese C, Grisanti S, Bruni A, Scorsetti M. Clin Lung Cancer. 2024 Mar;25(2):151-158. doi: 10.1016/j.cllc.2023.11.005. Epub 2023 Nov 17.
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
Nicosia L, Franceschini D, Perrone-Congedi F, Molinari A, Gerardi MA, Rigo M, Mazzola R, Perna M, Scotti V, Fodor A, Iurato A, Pasqualetti F, Gadducci G, Chiesa S, Niespolo RM, Bruni A, Cappelli A, D’Angelo E, Borghetti P, Di Marzo A, Ravasio A, De Bari B, Sepulcri M, Aiello D, Mortellaro G, Sangalli C, Franceschini M, Montesi G, Aquilanti FM, Lunardi G, Valdagni R, Fazio I, Scarzello G, Vavassori V, Maranzano E, Maria Magrini S, Arcangeli S, Gambacorta MA, Valentini V, Paiar F, Ramella S, Di Muzio NG, Loi M, Jereczek-Fossa BA, Casamassima F, Osti MF, Scorsetti M, Alongi F.